Thailand Regulatory Update: Thai FDA warns against misleading hemorrhoid claims for Dr.Harry Comfort Zone Cream
Thai FDA issued a public warning on misleading therapeutic claims for Dr.Harry Comfort Zone Cream, advising consumers not to believe it can treat hemorrhoids.
This week in Thailand, the Thai FDA published a public warning on misleading therapeutic claims for a product marketed as a medicine. The announcement advises consumers not to believe claims that Dr.Harry Comfort Zone Cream can treat hemorrhoids. No registration action, recall, or enforcement outcome was described in the page text provided.
Update
- Thai FDA news page: warning on Dr.Harry Comfort Zone Cream and claims that it can treat hemorrhoids. The notice highlights misleading therapeutic claims; no further registration or enforcement details were included in the source text.
Related markets: Thailand
Ready to Enter Asian Markets?
PECAN.Solutions is your trusted partner for navigating the complex regulatory landscape of Asian pharmaceutical markets. With our network of local experts and proven track record since 2007, we can help you bring your products to market efficiently and compliantly.
Contact us today to discuss your Asian market entry strategy and learn how we can accelerate your regulatory success.
Contact Us